title: Letter to the editor concerning 'Trastuzumab emtansine (T-DM1) versus lapatinib plus capecitabine in patients with HER2-positive metastatic breast cancer and central nervous system metastases: a retrospective, exploratory analysis in EMILIA'.
authors: Department of Medical Oncology, S. Maria Della Misericordia Hospital, Perugia. Electronic address: jennifer.foglietta@libero.it.
authors: J
authors: J
authors: Foglietta
authors: Department of Medical Oncology, S. Maria Della Misericordia Hospital, Perugia.
authors: G
authors: G
authors: Metro
authors: Department of Medical Oncology, S. Maria Della Misericordia Hospital, Perugia.
authors: L
authors: L
authors: Crinò
authors: Department of Medical Oncology, Sacro Cuore Don Giuseppe Calabria, Negrar, Italy.
authors: S
authors: S
authors: Gori
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy*; D016543:Central Nervous System Neoplasms / Q000556:secondary*; D003841:Deoxycytidine / Q000031:analogs & derivatives*; D005260:Female; D005472:Fluorouracil / Q000031:analogs & derivatives*; D006801:Humans; D008453:Maytansine / Q000031:analogs & derivatives*; D011799:Quinazolines / Q000627:therapeutic use*
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D011799:Quinazolines; D003841:Deoxycytidine; D008453:Maytansine; D005472:Fluorouracil